Study uncovers genes that drive peanut allergy reactions
Can't see this email? View it online
   
  December 12, 2017  
  Allergy  
  The latest Allergy news from News Medical  
 Study uncovers genes that drive peanut allergy reactionsStudy uncovers genes that drive peanut allergy reactions
 
Mount Sinai researchers have identified six genes that activate hundreds of other genes in children experiencing severe allergic reactions to peanuts.
 
 
 Children with high blood levels of polyunsaturated fatty acids less likely to develop asthma or rhinitisChildren with high blood levels of polyunsaturated fatty acids less likely to develop asthma or rhinitis
 
New research from Karolinska Institutet in Sweden reveals that high levels of polyunsaturated fatty acids in children's blood are associated with a reduced risk of asthma or rhinitis at the age of 16 years. The study is published in The Journal of Allergy and Clinical Immunology.
 
   BU researchers receive $2.7 million grant to find better ways of delivering anti-retroviralsBU researchers receive $2.7 million grant to find better ways of delivering anti-retrovirals
 
Rahm Gummuluru, PhD, associate professor of microbiology at Boston University School of Medicine, and Bjoern Reinhard, PhD, professor of chemistry at Boston University, have been awarded a Research Project Grant from the National Institutes of Allergy and Infectious Diseases/National Institute of Health.
 
   New tests offer better chance for more accurate detection of Lyme diseaseNew tests offer better chance for more accurate detection of Lyme disease
 
New tests to detect early Lyme disease - which is increasing beyond the summer months -could replace existing tests that often do not clearly identify the infection before health problems occur.
 
   Investigational ZPIV vaccine found to be safe and immunogenic in trial participantsInvestigational ZPIV vaccine found to be safe and immunogenic in trial participants
 
The investigational Zika purified inactivated virus (ZPIV) vaccine was well-tolerated and induced an immune response in participants, according to initial results from three Phase 1 clinical trials.
 
 Attack on asthma: Scrubbing homes of allergens may tame disease and its costs
 
After years of studying the causes of asthma, a pediatrician-turned-public health sleuth thinks there's a way to substantially reduce its impact.
 
 
 First short-acting ‘follow-on’ insulin receives FDA approval to treat diabetes
 
First short-acting ‘follow-on’ insulin receives FDA approval to treat diabetesThe U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pediatric patients aged 3 years and older with type 1 diabetes mellitus and adults with type 2 diabetes mellitus.
 
 
 Researchers discover potential regulator essential for killer T cells to reside in tumors
 
Researchers discover potential regulator essential for killer T cells to reside in tumorsResearchers report the discovery that a protein called "Runx3" programs killer T cells to establish residence in tumors and infection sites.